Study: Nearly half of heart attack and stroke survivors don’t know their LDL cholesterol levels

SAN FRAN­CIS­CO — The bio­phar­ma ex­trav­a­gan­za that is the JP Mor­gan Health­care Con­fer­ence start­ed to wind down Wednes­day. Here’s what we’re hear­ing on Wednes­day around

It’s a clas­sic bio­phar­ma sto­ry. In Jan­u­ary, David Khougaz­ian bumped in­to Flag­ship Pi­o­neer­ing founder Noubar Afeyan at the JP Mor­gan health­care con­fer­ence. They caught up,